Stock Price
14.96
Daily Change
0.09 0.61%
Monthly
-7.08%
Yearly
-23.87%
Q1 Forecast
14.69

Adma Biologics reported $206.46M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Adma Biologics USD 206.46M 9.8M Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
BioCryst Pharmaceuticals USD 5.4M 166K Dec/2025
Novavax USD 11.54M 1.97M Dec/2025
Omeros USD 712K 266K Sep/2021
Takeda JPY 1.41T 107.71B Dec/2025